Life Sciences
Below are all our articles under the above category.
Will Ozempic hurt healthcare stocks? Here are 5 reasons we don’t think so
Will Ozempic hurt healthcare stocks? Investors who’ve been selling healthcare stocks left right and centre – except Novo Nordisk of…
ESG Investing in 2024: How can I tell if a stock or fund is ethical or ESG compliant?
ESG investing is becoming increasingly popular with investors. But as this happens, it begs the question as to just how you…
4D Medical (ASX:4DX) could become the next Pro Medicus, it’s a long way to the top
There’s not many Australian radiology companies that seek to conquer the USA, but 4D Medical (ASX:4DX) is one of them.…
Is CSL (ASX:CSL) now facing a more difficult FY24 than investors first thought?
After a decade of nothing but good news for investors in CSL (ASX:CSL), shares fell by ~25% between June and…
Nova Eye Medical (ASX:EYE) has been on a strong run, up 50% in one month. Is there more upside?
Nova Eye Medical (ASX:EYE) has had a good month. The optometry company obtained FDA clearance for its newest generation canaloplasty device…
Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?
In the past year, biotech shares have performed poorly. Why has this been the case and will things be better…
Which ASX health stocks might get FDA approval in 2023?
It is the dream of many ASX health stocks and their investors for their company’s device or drug to be…
Immutep (ASX: IMM) has massive potential!
Immutep (ASX: IMM) develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. It has several product candidates at…
Actinogen Medical (ASX: ACW): Good news on phase 2 trials can catapult this stock
Working on a new drug for Alzheimer’s disease Actinogen Medical (ASX: ACW) is a Sydney-based biotechnology company working on finding…
Pfizer delivers the goods on a COVID-19 vaccine
10 November 2020 One of the reasons investors can be optimistic about 2021 is the speed with which the first…